Clinuvel Pharmaceuticals Ltd. (CUVL) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

—

Market Cap

$328.79M

MomentumView details →

1D Return

+3.82%

YTD Return

—

RSI (14)

40.3

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

—

Market Cap

$328.79M

RSI (14)

40.3

MomentumView details →

1D Return

+3.82%

YTD Return

—

ProfitabilityView details →

Gross Margin

—

Net Margin

—

EBITDA Margin

—

ROE (TTM)

—

ROA (TTM)

—

Asset Turnover

—

GrowthView details →

Revenue YoY

—

EPS YoY

—

FCF YoY

—

Revenue CAGR 3Y

—

EPS CAGR 3Y

—

EBITDA YoY

—

EarningsView details →

EPS (Actual)

$0.34

EPS Surprise

−3.46%

Beats (12Q)

0/12

Next Q EPS Est

—

Avg Surprise (4Q)

−3.46%

Rev Surprise

−2.76%

Capital & dividendView details →

Debt/Equity

—

Current Ratio

—

Quick Ratio

—

Div Yield

—

Div Rate

—

Div Growth 1Y

—

Financials snapshotView financials →

Revenue (TTM)

—

Net Income (TTM)

—

Op. CF (TTM)

—

Next earningsFeb 23, 2027 →

Latest newsMore news →

No recent news for CUVL.

Similar companies

Vicore Pharma Holding ABVCRE Kingworld Medicines Group Limited01110.HK High Tide Inc.HITI Tycoon Group Holdings Limited03390.HK Satellos Bioscience Inc. Common StockMSLE LifeMD, Inc.LFMD Find similar companies →

Latest newsMore news →

No recent news for CUVL.